Category Archives: Science

Science Press Releases & News distributed via EuropaWire

Empa Unveils Synchronized Floating Potential HiPIMS Method for Advanced Piezoelectric Thin Films at Low Temperatures

(IN BRIEF) Researchers at Empa have developed a revolutionary process for producing high-quality piezoelectric thin films at low temperatures using the Synchronized Floating Potential HiPIMS (SFP-HiPIMS) method. This process enables the production of piezoelectric films on insulating substrates, which are … Read the full press release

Viessmann Foundation Donates €5.6 Million to DKFZ for Cancer Prevention and Pediatric Oncology Research

(IN BRIEF) The Viessmann Foundation has donated €5.6 million to the German Cancer Research Center (DKFZ) to advance research into cancer prevention through nutrition and the development of new treatments for pediatric oncology. This five-year funding will support vital research … Read the full press release

European Commission Approves New Evrysdi Tablet, Offering Enhanced Flexibility for SMA Treatment

(IN BRIEF) Roche announced the European Commission’s approval of a label extension for Evrysdi® (risdiplam) to include a new 5mg tablet, offering a room-temperature stable alternative to the original oral solution for individuals with spinal muscular atrophy (SMA). The tablet, … Read the full press release

EIB and Leyden Labs Secure €20 Million Financing to Advance Pandemic Preparedness with Innovative Nasal Spray

(IN BRIEF) The European Investment Bank (EIB) has signed a €20 million financing deal with Leyden Laboratories to support the development of its innovative pan-influenza nasal spray, which aims to protect against seasonal and pandemic viral infections. The funding, guaranteed … Read the full press release

Sanofi’s Rilzabrutinib Granted Fourth Orphan Drug Designation, Now Targeting Sickle Cell Disease

(IN BRIEF) Rilzabrutinib, an oral Bruton’s tyrosine kinase (BTK) inhibitor, has received orphan drug designation from the U.S. FDA for sickle cell disease. This marks the fourth such designation for the drug, which has already been recognized for its potential … Read the full press release

University of Helsinki Research Offers New Insight Into Cancer Treatment, Paving the Way for Personalized Therapies

(IN BRIEF) A study by the University of Helsinki has uncovered why some breast cancer treatments, including immunotherapy, may not be effective for all patients. The research, focusing on the mechanical properties of tumor tissue, shows that softer tissue environments … Read the full press release

TUM Alumnus Emmanuel Adjei Embarks on 10,000-Kilometer Charity Ride to Promote Educational Equity in Africa

(IN BRIEF) Emmanuel Adjei, a sports scientist at TUM, embarks on a 10,000-kilometer charity ride from Munich to Accra to promote educational equity and raise funds for the NGO EduSpots. Starting on June 7, 2025, the journey will cover 15 … Read the full press release

TUM Study Finds Green Hydrogen from Africa More Expensive Than Expected, Recommends Policy Interventions

(IN BRIEF) A study led by TUM and supported by the University of Oxford has revealed that producing green hydrogen in Africa for export to Europe is much more expensive than previously assumed. Only a small fraction of potential production … Read the full press release

Newcastle University’s Discover Festival to Showcase Cutting-Edge Research and Interactive Activities

(IN BRIEF) Newcastle University’s Discover Festival, a free family-friendly event, will take place on Saturday, June 7, 2025, offering a day of interactive learning and entertainment. Over 70 activities will showcase the university’s pioneering research, including hands-on experiences in robotics, … Read the full press release

Newcastle University Breakthrough Identifies New Treatment for ICB-Resistant Skin Cancers

(IN BRIEF) Researchers at Newcastle University have discovered a new biological mechanism explaining why some patients do not respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors. They identified T regulatory cells (Tregs) as key drivers of ICB … Read the full press release

University of Glasgow Appoints Professor Emma Thomson as Permanent Director of CVR, Leading Advancements in Virus Research

(IN BRIEF) The University of Glasgow has appointed Professor Emma Thomson as the new Director of the MRC-University of Glasgow Centre for Virus Research (CVR), after she served as Interim Director from February. An expert in emerging infectious diseases, Professor … Read the full press release

Novartis Announces Positive Interim Results for Pluvicto™ in Early-Stage Prostate Cancer, Meeting Primary Endpoint in Phase III PSMAddition Trial

(IN BRIEF) Novartis has announced that its Phase III PSMAddition trial of Pluvicto™ in combination with standard of care (SoC) has met its primary endpoint, showing a significant benefit in radiographic progression-free survival (rPFS) and a positive trend in overall … Read the full press release

Novartis Presents ASCO Data Showing Kisqali’s Efficacy and Tolerability in High-Risk Early Breast Cancer Patients

(IN BRIEF) Novartis has presented new data from the Phase III NATALEE trial at ASCO 2025, showcasing Kisqali’s ability to reduce the risk of recurrence in pre-menopausal patients with high-risk early breast cancer. The data reveals a 33% reduction in … Read the full press release

Eckert & Ziegler Hosts Successful 3rd Boston Radionuclide Theranostics Forum to Shape the Future of Precision Oncology

(IN BRIEF) Eckert & Ziegler successfully hosted the 3rd annual Boston Radionuclide Theranostics Forum, bringing together industry leaders to discuss radionuclide theranostics’ role in transforming precision oncology. The event featured expert presentations on advancements in radiopharmaceuticals, clinical development challenges, and … Read the full press release

Fresenius Medical Care Unveils Groundbreaking Research and Innovations in Kidney Care at ERA Congress

(IN BRIEF) Fresenius Medical Care will showcase a variety of new research at the 62nd Congress of the European Renal Association (ERA) in Vienna, focusing on advancements in kidney care, artificial intelligence, fluid management, and hemodiafiltration. Key studies include the … Read the full press release

Roche’s Fenebrutinib Demonstrates Promising Results with Low Relapse Rates and No Disability Progression in Phase II Multiple Sclerosis Study

(IN BRIEF) Roche presented promising 96-week data from the Phase II FENopta study, showing that its investigational drug, fenebrutinib, significantly reduced relapse rates and prevented disability progression in patients with relapsing multiple sclerosis (RMS). The study revealed an annualized relapse … Read the full press release

Itepekimab Shows Positive Results in COPD Phase 3 Study, Reducing Exacerbations in AERIFY-1 Trial

(IN BRIEF) Itepekimab, developed by Sanofi and Regeneron, met its primary endpoint in the AERIFY-1 phase 3 study for COPD, showing a 27% reduction in moderate or severe exacerbations at 52 weeks. However, the AERIFY-2 study did not achieve the … Read the full press release

Valio Partners in PRIMARY Project to Explore Grass Biorefineries and Sustainable Solutions for the Agricultural Sector

(IN BRIEF) Valio is a key partner in the EU-funded PRIMARY project, which aims to transform agricultural by-products into valuable resources. As part of the project, Valio is exploring grass biorefinery innovations, including using grass juice to fortify feed protein … Read the full press release

SGS Gains OSHA Approval to Add Five New NRTL Locations in Europe and Asia, Expanding Product Certification Services

(IN BRIEF) SGS has received approval from OSHA to expand its global network of Nationally Recognized Testing Laboratories (NRTLs) to new locations in Europe and Asia. Starting January 22, 2025, SGS will provide testing and certification for U.S. market products … Read the full press release

SGS’s Comprehensive Seed Testing Network Supports Canadian Growers with Advanced Solutions for Competitive Agriculture

(IN BRIEF) SGS has strengthened its support for Canadian farmers by offering extensive seed testing services across the country, combining local expertise with global testing standards. With laboratories in key agricultural regions such as Grande Prairie and Sherwood Park, SGS … Read the full press release